|2.87 -0.13 (-4.33%)||12-01 15:59|
|Targets||6-month :||4.11||1-year :||4.59|
|Resists||First :||3.52||Second :||3.93|
|Supports||First :||2.85||Second :||2.37|
|MAs||MA(5) :||3.03||MA(20) :||3.41|
|MA(100) :||3.33||MA(250) :||2.8|
|MACD||MACD :||-0.2||Signal :||-0.1|
|%K %D||K(14,3) :||1.7||D(3) :||3.5|
|52-week||High :||5.9||Low :||1.22|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CHEK ] has closed above bottom band by 1.7%. Bollinger Bands are 1.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|If tomorrow:||Open lower||Open higher|
|High:||3.05 - 3.07||3.07 - 3.09|
|Low:||2.86 - 2.89||2.89 - 2.9|
|Close:||2.88 - 2.91||2.91 - 2.94|
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Diagnostics & Research
|Shares Out||6 (M)|
|Shares Float||5 (M)|
|Held by Insiders||0.1 (%)|
|Held by Institutions||2.5 (%)|
|Shares Short||86 (K)|
|Shares Short P.Month||123 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||5.15|
|Profit Margin||0 %|
|Operating Margin||0 %|
|Return on Assets (ttm)||-28.8 %|
|Return on Equity (ttm)||-49.8 %|
|Qtrly Rev. Growth||0 %|
|Gross Profit (p.s.)||0|
|Sales Per Share||0|
|Qtrly Earnings Growth||0 %|
|Operating Cash Flow||-18 (M)|
|Levered Free Cash Flow||-12 (M)|
|Price to Book value||0.55|
|Price to Sales||0|
|Price to Cash Flow||-0.93|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|